BONE MINERAL DENSITY IN MEN TREATED WITH SYNTHETIC GONADOTROPIN-RELEASING HORMONE AGONISTS FOR PROSTATIC CARCINOMA

This publication has 10 references indexed in Scilit:

• Management of male osteoporosis: report of the UK Consensus Group.
  QJM: An International Journal of Medicine, 1998
• Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older
  New England Journal of Medicine, 1997
• Overview of role of BMD measurements in managing osteoporosis
  Seminars in Nuclear Medicine, 1997
• Gonadotrophin-releasing Hormone Agonists Induce Osteoporosis
  Rheumatology, 1994
• Sex hormones and bone mineral density in elderly men
  Bone and Mineral, 1993
• Relationship between gonadotrophin-releasing hormone analogue therapy and bone loss; a review
  Reproduction, Fertility and Development, 1991
• Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis
  Gynecological Endocrinology, 1990
• Increases in Bone Density During Treatment of Men with Idiopathic Hypogonadotropic Hypogonadism*
  Journal of Clinical Endocrinology & Metabolism, 1989
• Castrated Men Exhibit Bone Loss: Effect of Calcitonin Treatment on Biochemical Indices of Bone Remodeling*
  Journal of Clinical Endocrinology & Metabolism, 1989
• Osteoporosis in Men with Hyperprolactinemic Hypogonadism
  Annals of Internal Medicine, 1986